FDA Inspection
BloodworksBloodworks – FDA Inspection, May 3, 2024
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on May 3, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c6717275-d4f5-4c45-adc7-b32b8f50196e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1238690
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 211.84(d)(1)Component identity verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bloodworks
15| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2025 | Not classified | Seattle District Office | Blood and Blood Products |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 18, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 7, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 4, 2018 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Bloodworks
- FDA Inspection 1294906 - 2025-12-11
- FDA Inspection 1146276 - 2021-07-16
- FDA Inspection 1087821 - 2019-04-18
- FDA Inspection 1056331 - 2018-06-07
- FDA Inspection 1052060 - 2018-05-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.